Literature DB >> 28987805

Emergence of carbapenem resistant Escherichia coli isolates producing blaNDM and blaOXA-48-like carried on IncA/C and IncL/M plasmids at two Iranian university hospitals.

Hamid Solgi1, Christian G Giske2, Farzad Badmasti1, Shadi Aghamohammad1, Seyed Asghar Havaei3, Shahram Sabeti4, Kamyar Mostafavizadeh5, Fereshteh Shahcheraghi6.   

Abstract

The emergence of carbapenem resistance among Escherichia coli is a serious threat to public health. The objective of this study was to investigate resistance genes and clonality of carbapenem resistant E. coli in Iran. Between February 2015 and July 2016, a total of 32 non-duplicate E. coli isolates that were ertapenem resistant or intermediate (R/I-ETP) were collected from patient clinical or surveillance cultures (rectal swabs) at two university hospitals. Resistance genes were identified by PCR and sequencing. Conjugation experiments, PCR-based replicon typing, PFGE and multilocus sequence typing (MLST) were performed. PCR assays showed, among the 32 isolates, twenty-nine strains produced carbapenemase genes. The predominant carbapenemase was blaOXA-48 (82.8%), followed by blaNDM-1 (31%), blaNDM-7 (6.9%) and blaOXA-181 (3.4%). Seven of the blaNDM positive isolates co-harbored blaOXA-48 carbapenemases. The blaNDM and blaOXA-48 were found in IncA/C and IncL/M conjugative plasmids, respectively. The blaCTX-M-15, qnrA and intI1 genes were also present in most isolates. The PFGE revealed genetic diversity among the 28 E. coli isolates, which belonged to six minor PFGE clusters and 14 isolates were singletons. The 26 isolates were distributed into 18 STs, of which two were dominant (ST648 and ST167). We identified one blaNDM-1-positive ST131 E. coli isolates that harbor the blaCTX-M-15 and blaTEM genes. Horizontal transfer of IncA/C and IncL/M plasmids has likely facilitated the spread of the blaOXA-48 and blaNDM genes among E. coli. Their clonal diversity and the presence of faecal carriers in isolates suggest an endemic spread of OXA-48 and NDM. Therefore, it emphasizes the critical importance of monitoring and controlling the spread of carbapenem resistant E. coli.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Carbapenemase; Escherichia coli; MLST; PCR-based replicon typing; PFGE

Mesh:

Substances:

Year:  2017        PMID: 28987805     DOI: 10.1016/j.meegid.2017.10.003

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  16 in total

Review 1.  OXA-48-Like β-Lactamases: Global Epidemiology, Treatment Options, and Development Pipeline.

Authors:  Sara E Boyd; Alison Holmes; Richard Peck; David M Livermore; William Hope
Journal:  Antimicrob Agents Chemother       Date:  2022-07-20       Impact factor: 5.938

2.  Prevalence of plasmid-encoded carbapenemases in multi-drug resistant Escherichia coli from patients with urinary tract infection in northern Iran.

Authors:  Mahshid Deldar Abad Paskeh; Mohammad Javad Mehdipour Moghaddam; Zivar Salehi
Journal:  Iran J Basic Med Sci       Date:  2020-05       Impact factor: 2.699

Review 3.  Molecular Mechanisms, Epidemiology, and Clinical Importance of β-Lactam Resistance in Enterobacteriaceae.

Authors:  Giulia De Angelis; Paola Del Giacomo; Brunella Posteraro; Maurizio Sanguinetti; Mario Tumbarello
Journal:  Int J Mol Sci       Date:  2020-07-18       Impact factor: 5.923

4.  Molecular Epidemiology of OXA-48 and NDM-1 Producing Enterobacterales Species at a University Hospital in Tehran, Iran, Between 2015 and 2016.

Authors:  Hamid Solgi; Shoeib Nematzadeh; Christian G Giske; Farzad Badmasti; Fredrik Westerlund; Yii-Lih Lin; Gaurav Goyal; Vajihe Sadat Nikbin; Amir Hesam Nemati; Fereshteh Shahcheraghi
Journal:  Front Microbiol       Date:  2020-05-28       Impact factor: 5.640

5.  Cross-border spread of blaNDM-1- and blaOXA-48-positive Klebsiella pneumoniae: a European collaborative analysis of whole genome sequencing and epidemiological data, 2014 to 2019.

Authors:  Catherine Ludden; Felix Lötsch; Erik Alm; Narender Kumar; Karin Johansson; Barbara Albiger; Te-Din Huang; Olivier Denis; Anette M Hammerum; Henrik Hasman; Jari Jalava; Kati Räisänen; Laurent Dortet; Agnès B Jousset; Sören Gatermann; Sebastian Haller; Martin Cormican; Wendy Brennan; Maria Del Grosso; Monica Monaco; Leo Schouls; Ørjan Samuelsen; Mateja Pirš; Tjaša Cerar; Jésus Oteo-Iglesias; Maria Pérez-Vázquez; Karin Sjöström; Petra Edquist; Katie L Hopkins; Marc J Struelens; Daniel Palm; Dominique L Monnet; Anke Kohlenberg
Journal:  Euro Surveill       Date:  2020-05

Review 6.  Extended-spectrum β-lactamase-producing and carbapenemase-producing Enterobacteriaceae.

Authors:  Hayley Wilson; M Estée Török
Journal:  Microb Genom       Date:  2018-07-23

7.  Comparative Genome Analysis of an Extensively Drug-Resistant Isolate of Avian Sequence Type 167 Escherichia coli Strain Sanji with Novel In Silico Serotype O89b:H9.

Authors:  Xiancheng Zeng; Xuelin Chi; Brian T Ho; Damee Moon; Christine Lambert; Richard J Hall; Primo Baybayan; Shihua Wang; Brenda A Wilson; Mengfei Ho
Journal:  mSystems       Date:  2019-02-26       Impact factor: 6.496

Review 8.  Understanding the Epidemiology of Multi-Drug Resistant Gram-Negative Bacilli in the Middle East Using a One Health Approach.

Authors:  Iman Dandachi; Amer Chaddad; Jason Hanna; Jessika Matta; Ziad Daoud
Journal:  Front Microbiol       Date:  2019-08-23       Impact factor: 5.640

9.  Evaluation of Phenotypic and Genotypic Characteristics of Carbapnemases-producing Enterobacteriaceae and Its Prevalence in a Referral Hospital in Tehran City.

Authors:  Kosar Jalalvand; Nasrin Shayanfar; Fereshteh Shahcheraghi; Elahe Amini; Mahsa Mohammadpour; Pegah Babaheidarian
Journal:  Iran J Pathol       Date:  2020-02-28

10.  The Phylogenetic Relatedness of bla NDM-1 Harboring Extended-Spectrum β-Lactamase Producing Uropathogenic Escherichia coli and Klebsiella pneumoniae in the North of Iran.

Authors:  Samar Jamali; Talayeh Tavakoly; Ali Mojtahedi; Mohammad Shenagari
Journal:  Infect Drug Resist       Date:  2020-02-25       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.